Literature DB >> 11141228

Transcription factor NF kappa B expression and postsurgical organ dysfunction.

S Foulds1, C Galustian, A O Mansfield, M Schachter.   

Abstract

OBJECTIVE: To examine the role of neutrophil NF kappa B activation in organ dysfunction after major surgery. SUMMARY BACKGROUND DATA: NF kappa B is a transcription factor involved in the signal transduction of many stimuli that may participate in the pathogenesis of sepsis and resultant multiple organ dysfunction syndrome (MODS). It may therefore be a potential target for modulation in the reduction of postsurgical MODS.
METHODS: Twenty-five patients undergoing major vascular surgery (thoracoabdominal aortic aneurysm repair) were studied. Perioperative levels of neutrophil NF kappa B, CD11b, and glutathione were measured. In vitro inhibition experiments using NF kappa B inhibitors were also performed.
RESULTS: No differences in clinical parameters were apparent before surgery between the patients who subsequently developed MODS and those who did not. However, there was a significant difference in preoperative levels of NF kappa B between the patients who developed postoperative organ dysfunction and those who did not. There was also a significant preoperative difference between patients who survived surgery and those who did not. Glutathione levels were reduced both in patients who developed MODS and those who did not at the onset of surgery. NF kappa B inhibitors suppressed patient plasma-stimulated NF kappa B activation in healthy neutrophils.
CONCLUSIONS: Preoperative neutrophil NF kappa B status may be a marker of postoperative outcome after major surgery, and therapy aimed at attenuating neutrophil NF kappa B activation may reduce postoperative sepsis and organ dysfunction.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11141228      PMCID: PMC1421169          DOI: 10.1097/00000658-200101000-00012

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  49 in total

Review 1.  The intestinal factor in multiple organ failure and shock.

Authors:  G Bounous
Journal:  Surgery       Date:  1990-01       Impact factor: 3.982

Review 2.  Evolving strategies in the treatment of sepsis and systemic inflammatory response syndrome (SIRS).

Authors:  K D Horn
Journal:  QJM       Date:  1998-04

3.  Novel flow cytometric method for quantifying nuclear binding of the transcription factor nuclear factor kappa B in unseparated human monocytes and polymorphonuclear cells.

Authors:  S Foulds
Journal:  Cytometry       Date:  1997-10-01

4.  Flow-cytometric determination of glutathione alterations in vital cells by o-phthaldialdehyde (OPT) staining.

Authors:  J Treumer; G Valet
Journal:  Exp Cell Res       Date:  1986-04       Impact factor: 3.905

5.  Human toxic neutrophils. 3. Metabolic characteristics.

Authors:  C E McCall; L R DeChatelet; M R Cooper; C Shannon
Journal:  J Infect Dis       Date:  1973-01       Impact factor: 5.226

6.  Fc gamma receptor III on human neutrophils. Allelic variants have functionally distinct capacities.

Authors:  J E Salmon; J C Edberg; R P Kimberly
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

7.  Differential activation of mixed venous and arterial neutrophils in patients with sepsis syndrome and acute lung injury.

Authors:  A Nahum; W Chamberlin; J I Sznajder
Journal:  Am Rev Respir Dis       Date:  1991-05

8.  Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group.

Authors:  E J Ziegler; C J Fisher; C L Sprung; R C Straube; J C Sadoff; G E Foulke; C H Wortel; M P Fink; R P Dellinger; N N Teng
Journal:  N Engl J Med       Date:  1991-02-14       Impact factor: 91.245

9.  Nuclear factor kappaB is activated in macrophages and epithelial cells of inflamed intestinal mucosa.

Authors:  G Rogler; K Brand; D Vogl; S Page; R Hofmeister; T Andus; R Knuechel; P A Baeuerle; J Schölmerich; V Gross
Journal:  Gastroenterology       Date:  1998-08       Impact factor: 22.682

10.  Altered neutrophil migration during bacterial infection associated with a serum modulator of cellular motility.

Authors:  A S Link; D A Bass; C E McCall
Journal:  J Infect Dis       Date:  1979-10       Impact factor: 5.226

View more
  9 in total

1.  Nuclear factor kB activity in patients with acute severe cholangitis.

Authors:  Jian-Ping Gong; Chong-An Liu; Chuan-Xin Wu; Sheng-Wei Li; Yu-Jun Shi; Xu-Hong Li
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

Review 2.  NF-kappaB in critical diseases: a bad guy?

Authors:  Uwe Senftleben
Journal:  Intensive Care Med       Date:  2003-09-04       Impact factor: 17.440

Review 3.  Polyphenols in the treatment of inflammatory bowel disease and acute pancreatitis.

Authors:  Haim Shapiro; Pierre Singer; Zamir Halpern; Rafael Bruck
Journal:  Gut       Date:  2006-08-24       Impact factor: 23.059

4.  Ecto-5'-nucleotidase (CD73) decreases mortality and organ injury in sepsis.

Authors:  György Haskó; Balázs Csóka; Balázs Koscsó; Rachna Chandra; Pál Pacher; Linda F Thompson; Edwin A Deitch; Zoltán Spolarics; László Virág; Pál Gergely; Rolando H Rolandelli; Zoltán H Németh
Journal:  J Immunol       Date:  2011-09-14       Impact factor: 5.422

Review 5.  Novel strategies for the treatment of inflammatory hyperalgesia.

Authors:  Atul R Chopade; Wahid A Mulla
Journal:  Eur J Clin Pharmacol       Date:  2010-02-13       Impact factor: 2.953

6.  Role of NF-kB in multiple organ dysfunction during acute obstructive cholangitis.

Authors:  Bin Tu; Jian-Ping Gong; Hu-Yi Feng; Chuan-Xin Wu; Yu-Jun Shi; Xu-Hong Li; Yong Peng; Chang-An Liu; Sheng-Wei Li
Journal:  World J Gastroenterol       Date:  2003-01       Impact factor: 5.742

7.  Postoperative evolution of inflammatory response in a model of suprarenal aortic cross-clamping with and without hemorrhagic shock. Systemic and local reactions.

Authors:  Francisco S Lozano; José M Rodriguez; Francisco J Garcia-Criado; Marcello B Barros; Pilar S Conde; Luis M Gonzalez; Manuel Rodriguez; Alberto Gomez-Alonso
Journal:  World J Surg       Date:  2005-10       Impact factor: 3.282

Review 8.  Neo-intimal hyperplasia, diabetes and endovascular injury.

Authors:  Deirdre Kruger
Journal:  Cardiovasc J Afr       Date:  2012-05-22       Impact factor: 1.167

9.  The protective effects of PCPA against monocrotaline-induced pulmonary arterial hypertension are mediated through the downregulation of NFAT-1 and NF-κB.

Authors:  Yang Bai; Zhong-Xia Li; Huai-Liang Wang; Guo-Chao Lian; Yun Wang
Journal:  Int J Mol Med       Date:  2017-05-26       Impact factor: 4.101

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.